Clinical study of apatinib combined with EGFR‐TKI in the treatment of chronic progression after EGFR‐TKI treatment in non‐small cell lung cancer (ChiCTR1800019185)

This clinical trial (ChiCTR1800019185) is designed to be an open‐label, prospective, single‐center, single arm exploratory research study. The study will recruit non‐small cell lung cancer patients (NSCLC) with slow progression after first‐line treatment with EGFR‐TKI drugs. Slow progression will be...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Liu, Minghui, Zhang, Hongbing, Liu, Hongyu, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049491/
https://www.ncbi.nlm.nih.gov/pubmed/31918452
http://dx.doi.org/10.1111/1759-7714.13303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049491/
https://www.ncbi.nlm.nih.gov/pubmed/31918452
http://dx.doi.org/10.1111/1759-7714.13303

Ejemplares similares